Latest News & Features
Americas
The Supreme Court of Canada heard oral arguments in AstraZeneca v Apotex and reserved its decision about patent utility and the ‘promise doctrine’, in a case centring on pharmaceutical company AstraZeneca’s heartburn relief drug Nexium. 11 November 2016
Americas
The US Court of Appeals for the Federal Circuit issued a mixed ruling on a case yesterday between medical device company NuVasive and the US Patent and Trademark Office’s Patent Trial and Appeal Board. 10 November 2016
article
The regents of the University of California, the institution’s governing body, has filed a complaint against US-based medical device company AtriCure for allegedly infringing patents covering a method of treating atrial fibrillation. 10 November 2016
Americas
Philips has agreed to make a $300 million cash payment in a multi-year partnership with Masimo, a health technology company. 9 November 2016
Asia
Pharmaceutical company GSK has triumphed in a trademark infringement dispute in India. 9 November 2016
Americas
A US official has spoken about the approach that the Centers for Medicare & Medicaid Services has taken towards innovation in the past year. 8 November 2016
Americas
The US Supreme Court yesterday denied a petition for certiorari in a case centring on Lamictal, a treatment for certain types of seizures as well as bipolar disorder. 8 November 2016
Big Pharma
To overcome a crowded patent market, a potential solution is to seek a declaration of obviousness, which has a basis in UK law stemming from Arrow Generics v Merck. Richard Roberts of Potter Clarkson reports. 8 November 2016
Americas
US-based Amarin Pharma has filed a complaint against Dr Reddy’s Laboratories for allegedly infringing 14 patents covering Vascepa. 7 November 2016
Big Pharma
The IP Life Sciences Exchange, an event for senior IP decision-makers from the life sciences sector, will take place on November 15 and 16 in Munich, Germany. LSIPR previews some of the most interesting sessions. 7 November 2016